AG
NAMS icon

Algert Global’s NewAmsterdam Pharma NAMS Stock Holding History

Algert Global’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
+81,340
New +$2.68M 0.03% 755
2025
Q3 		– Sell
-18,140
Closed -$329K – 1273
2025
Q2 		$329K Buy
+18,140
New +$331K 0.01% 1013

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Algert Global's NAMS Position: Q2 2026 in Review

Algert Global opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 81,340 shares worth $2.76M. The stake represents 0.03% of the portfolio and ranks #755 among its holdings. This is a return to the name: Algert Global previously reported a position in NAMS as recently as Q2 2025.

Algert Global first reported a position in NAMS in Q2 2025 and has held it in 2 quarters since. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Algert Global held 81,340 shares of NewAmsterdam Pharma worth $2.76M as of Q2 2026.
  • NewAmsterdam Pharma was a new Algert Global position in Q2 2026.
  • NewAmsterdam Pharma made up 0.03% of Algert Global's portfolio in Q2 2026, its #755 holding.
  • Algert Global first reported a position in NewAmsterdam Pharma in Q2 2025 and has held it in 2 quarters since.
  • 195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.